Snyders, Travis http://orcid.org/0000-0003-2253-4217
Chakos, Daniel
Swami, Umang
Latour, Emile
Chen, Yiyi
Fleseriu, Maria
Milhem, Mohammed
Zakharia, Yousef
Zahr, Roula
Funding for this research was provided by:
Biostatistics Shared Resource, Knight Cancer Institute (NCI P30CA069533)
Article History
First Online: 20 July 2019
Compliance with ethical standards
:
: Travis Snyders declares that he has no conflict of interest. Daniel Chakos declares that he has no conflict of interest. Umang Swami declares that he has no conflict of interest. Emile Latour declares that he has no conflict of interest. Yiyi Chen declares that she has no conflicts of interest. Maria Fleseriu declares that she has no conflict of interest. Mohammed Milhem is a member of advisory boards for Amgen, Trieza, Biontech, Blueprint medicines corporation, Immunocore, and Array BioPharma, Inc. Yousef Zakharia is a member of advisory boards for Amgen, Roche diagnostics, Novartis, Jansen, Eisai, Exelixis, Castle Bioscience, Array, and Bayer. Roula Zahr declares that she has no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: The Institutional Review Board at the University of Iowa Hospitals and Clinics approved this study. As this was a retrospective review of patient data, individual informed consent was exempted by the Institutional review board.